Govt Approves Sinovac Jabs 'in The Public Interest'

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576185_1_20210218193250.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });

2021-02-18 HKT 12:16

Share this story

facebook

  • The approval of the Sinovac jabs comes just a day before the first doses are expected to arrive. Image: Shutterstock

    The approval of the Sinovac jabs comes just a day before the first doses are expected to arrive. Image: Shutterstock

The government on Thursday approved the use of a Covid-19 vaccine made by mainland firm Sinovac, describing it as a necessary move and one that is in the public interest.

Experts advising the SAR authorities on coronavirus vaccines said earlier this week that with a reported efficacy rate of 62.3 percent, the protection offered by the Sinovac jabs would outweigh any risks.

A million doses of the vaccine are expected to arrive in Hong Kong on Friday, with doctors anticipating that the vaccination programme could be rolled out as soon as next week.

A government statement said the secretary for health considered it necessary to approve the Sinovac jabs after considering the experts' opinion and the public health risks posed by the pandemic.

The statement said the government will complete the necessary quality checks after receiving the jabs, and will continue to ask Sinovac to provide it with the latest clinical data.

The SAR government eventually decided not to require the mainland company to publish clinical data in medical journals before its jabs could be approved here. The vaccine has so far not been approved by the World Health Organisation.

The Sinovac vaccine is the second approved for use in the SAR, after jabs made by German firm BioNTech were earlier given the green light.

RECENT NEWS

Ping An P&C And FAW Hongqi Launch Hongqi Intelligent Driving Protection Services

Ping An Property & Casualty Insurance Company of China (Ping An P&C), a subsidiary of Ping An Insurance, has pa... Read more

HKSTP European Innovation Mixer Tour Nurtures Global Ties For Hong Kong

The Hong Kong Science and Technology Parks Corporation (HKSTP), led by CEO Albert Wong, conducted the HKSTP European In... Read more

The Full List Of Fintech Unicorns In Hong Kong (2025)

Hong Kong’s fintech landscape has evolved into a dynamic force in Asia, driven by regulatory innovation, technologica... Read more

HKSTPs EPIC 2025 Competition Returns, Doubling Investment Pool To US$100M

The 9th edition of the Elevator Pitch International Competition, also known as the EPIC 2025 competition, officially op... Read more

RedotPay Secures $40 Million Series A Funding, To Advance Global Crypto Payment Solutions

RedotPay secures $40 million Series A funding, marking a major milestone for the crypto payment platform. The announcem... Read more

BOOM Hits $2 Billion In AUM, Reinvesting Into Crypto And Tokenised Securities

BOOM, a Hong Kong-based online investing platform for high-net-worth individuals, announced on 12 March 2025 that it ex... Read more